Su Xuefeng, a postdoctoral fellow at Harvard Medical School in the United States, has more than 20 years of research experience in medical research, famed for his solid knowledge foundation in biochemistry, molecular biology and cell biology as well as the rich experience in experimental design, practical operation and data analysis. Dr. Su is strong in analyzing and solving problems. He has published more than twenty articles in leading academic journals and magazines both at home and abroad, which has a good record of academic successes.

June, 2014: Harvard Medical School (postdoctoral)

May, 2008: University of Texas, Biochemistry (Ph.D.)

July, 1996: Institute of Biophysics, Chinese Academy of Sciences, Molecular Biology (Master)

July, 1993: Jilin University, Biochemistry (Bachelor)

Zhang Minghang is a Ph.D. in Molecular Genetics at University of Texas Health Science Center at Houston and a postdoctoral fellow in Molecular and Human Genetics at Baylor College of Medicine. Later in the United States, he started his own business, mainly carrying out scientific research services such as gene synthesis and high-throughput sequencing. After his returning to China, he started his own business and engaged in scientific research services and the development of molecular diagnostic products.

January, 2007: Department of Molecular and Human Genetics, Baylor College of Medicine (postdoctoral)

July, 2002: Department of Microbiology and Molecular Genetics, University of Texas Health Science Center at Houston (Ph.D.)

July, 1996: Molecular Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing (Master)

July, 1993: Microbiology, Wuhan University, Wuhan, Hubei (Bachelor)

With 20 years of experience in gene sequencing industry, Dr. Xiang is an industry-renowned scientist who has been involved in and led the research and development of the second and third generation of gene sequencing reagents since 1996.

1996-1998 Participated in the research and development of reagents for mass spectrometry gene sequencing;

2009-2010 Involved in the production of the first generation gene sequencing reagents;

2009-2011 Participated in Starlight, the R&D project of the third-generation gene sequencing reagents of Life Tech (ABI);

2011-2013 Participated in SOLID/Wildfire, the R&D project of the second-generation gene sequencing reagents of Life Tech (ABI);

2013-2016 Participated in the R&D of the second-generation gene sequencing reagents of Ion Torrent (Life Tech/Thermo Fisher) who occupies 20% of the sequencing market.